Lipid MetabolismMarch 18, 20264 min read

Q-Bank Breakdown: Ketogenesis — Why Every Answer Choice Matters

Clinical vignette on Ketogenesis. Explain correct answer, then systematically address each distractor. Tag: Biochemistry > Lipid Metabolism.

Q-Bank Breakdown: Ketogenesis — Why Every Answer Choice Matters

Tag: Biochemistry > Lipid Metabolism

Ketogenesis is a classic USMLE favorite because it ties together fasting physiology, insulin/glucagon signaling, mitochondrial biochemistry, and acid–base. In this breakdown, you’ll work through a clinical vignette and then learn why every answer choice matters—especially the distractors designed to trap you.

Clinical Vignette (USMLE-Style)

A 24-year-old man with type 1 diabetes is brought to the ED for abdominal pain, nausea, and rapid breathing. He has been feeling ill for 2 days and stopped taking insulin. Exam shows dehydration and deep, rapid respirations. Labs: glucose 560 mg/dL, bicarbonate 10 mEq/L, anion gap 24. Serum has elevated β-hydroxybutyrate.

Question: Which of the following processes is most directly responsible for the patient’s elevated ketone bodies?

Answer choices: A. Increased activity of HMG-CoA synthase in hepatic mitochondria
B. Increased conversion of acetyl-CoA to citrate in the TCA cycle
C. Increased malonyl-CoA production leading to enhanced fatty acid synthesis
D. Increased ketone utilization by peripheral tissues due to thiophorase upregulation
E. Increased hepatic glycolysis via fructose-2,6-bisphosphate activation

The Correct Answer: A. Increased activity of HMG-CoA synthase in hepatic mitochondria

Why it’s correct (mechanism)

In diabetic ketoacidosis (DKA), low insulin + high glucagon drives:

  • Adipose lipolysis → release of free fatty acids (FFAs)
  • Hepatic β-oxidation of FFAs → lots of acetyl-CoA and NADH
  • Oxaloacetate is pulled toward gluconeogenesis, limiting TCA flux
  • Excess acetyl-CoA is shunted into ketogenesis

The rate-limiting enzyme of ketogenesis is:

  • Mitochondrial HMG-CoA synthase (in hepatocytes)

This produces HMG-CoA (in mitochondria), which is then converted to:

  • Acetoacetate → can become β-hydroxybutyrate (favored when NADH is high)
  • Acetone (spontaneous decarboxylation; “fruity” breath)

High-yield enzyme map (know this cold)

  • Ketogenesis (liver mitochondria):
    • Rate-limiting: HMG-CoA synthase
    • Next: HMG-CoA lyase → acetoacetate
  • Ketone utilization (peripheral mitochondria):
    • Key enzyme: thiophorase (succinyl-CoA:acetoacetate CoA transferase)

USMLE pearl: The liver produces ketones but cannot use them because it lacks thiophorase.

Why the Patient Has High β-Hydroxybutyrate

In DKA, β-oxidation generates a lot of NADH, shifting acetoacetate → β-hydroxybutyrate.

Clinical tie-in: Urine dipsticks often detect acetoacetate, so early DKA can be underestimated if β-hydroxybutyrate predominates.

Systematic Distractor Breakdown (Why the other choices are wrong)

B. Increased conversion of acetyl-CoA to citrate in the TCA cycle

Tempting, because acetyl-CoA is abundant—but in DKA/fasting, TCA flux is limited.

Why it’s wrong

  • Oxaloacetate is diverted to gluconeogenesis, so there’s less OAA to condense with acetyl-CoA to form citrate.
  • High NADH from β-oxidation also inhibits TCA dehydrogenases, slowing the cycle.

High-yield: In fasting/DKA → TCA slows → acetyl-CoA accumulates → ketogenesis increases.

C. Increased malonyl-CoA production leading to enhanced fatty acid synthesis

This is basically the opposite metabolic state.

Why it’s wrong

  • Malonyl-CoA is produced by acetyl-CoA carboxylase (ACC), which is stimulated by insulin.
  • In DKA, insulin is low → ACC is inactive → malonyl-CoA decreases.

Key regulatory fact:

  • Malonyl-CoA inhibits CPT-I (carnitine palmitoyltransferase I), the transporter that brings long-chain fatty acids into mitochondria for β-oxidation.
  • In fasting/DKA: ↓malonyl-CoA → CPT-I disinhibited → ↑β-oxidation → ↑ketones.

So DKA physiology is: low malonyl-CoA, high β-oxidation, not fatty acid synthesis.

D. Increased ketone utilization by peripheral tissues due to thiophorase upregulation

Even if peripheral utilization changes, that would lower, not raise, circulating ketones.

Why it’s wrong

  • The question asks what’s responsible for elevated ketone bodies—that’s a production problem (liver), not a utilization increase.
  • Thiophorase is absent in the liver, so hepatic ketone utilization is not a factor.

High-yield:

  • Liver: makes ketones (has HMG-CoA synthase, lacks thiophorase)
  • Muscle/brain (during prolonged fasting): uses ketones (has thiophorase)

E. Increased hepatic glycolysis via fructose-2,6-bisphosphate activation

This describes fed state / insulin effect, not DKA.

Why it’s wrong

  • In DKA: insulin low, glucagon high → PFK-2 is phosphorylated → ↓fructose-2,6-bisphosphate → ↓glycolysis and ↑gluconeogenesis.
  • The liver is geared toward exporting glucose, not burning it.

Mnemonic:

  • Glucagon → phosphorylation → ↓F2,6-BP → ↓PFK-1 → ↓glycolysis

Ketogenesis: USMLE High-Yield Summary

When ketogenesis increases

  • Fasting/starvation
  • Uncontrolled diabetes (DKA)
  • Low-carbohydrate diets
  • Alcoholic ketoacidosis (often with low/normal glucose)

Where it happens

  • Liver mitochondria

What pushes acetyl-CoA toward ketones

  • Low insulin / high glucagon
  • Increased lipolysis (hormone-sensitive lipase active)
  • Increased β-oxidation → ↑acetyl-CoA, ↑NADH
  • Oxaloacetate depletion (pulled into gluconeogenesis)

Major ketone bodies

  • Acetoacetate
  • β-hydroxybutyrate (technically not a “true” ketone, but clinically the dominant one in DKA)
  • Acetone (fruity breath)

Acid–base and clinical correlations

  • Ketones are acids → anion gap metabolic acidosis
  • Respiratory compensation → Kussmaul respirations
  • DKA: total body potassium depleted even if serum K⁺ is normal/high (insulin deficiency + acidosis shift K⁺ out of cells)

Quick Exam Traps (Don’t Fall For These)

  • “HMG-CoA” ≠ always cholesterol.
    • Cytosolic HMG-CoA reductase → cholesterol synthesis
    • Mitochondrial HMG-CoA synthase → ketogenesis (rate-limiting)
  • Liver cannot use ketones (no thiophorase).
  • β-hydroxybutyrate predominates in DKA (high NADH), and urine dipsticks may miss the severity.

Take-Home

In DKA, ketones rise because the liver is flooded with fatty acids, ramps up β-oxidation, and—due to limited TCA capacity—shunts acetyl-CoA into ketone production via mitochondrial HMG-CoA synthase. The distractors mostly describe the fed state or processes that would reduce ketone levels.

Back to all articles